Del immune V and microbiome restructuring in colorectal cancer surgery: a randomized double blind placebo controlled trial. | ClinicLens
The gut microbiome is increasingly recognized as a central factor in carcinogenesis. Dietary components and therapeutic interventions, including probiotics, may influence microbial composition and function, thereby modulating cancer risk. Del-Immune V, a metabiotic supplement der
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.